Published in Lancet Respir Med on February 24, 2020
Outcomes and Prognostic Factors in COVID-19 (COVIP) | NCT04321265
Hemodynamic Characteristics of Patients With SARS-CoV-2 (PiCCOVID) | NCT04337983
Pyridostigmine in Severe SARS-CoV-2 Infection (PISCO) | NCT04343963
Asymptomatic COVID-19 Infection Among Healthcare Workers | NCT04354792
Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS (RuXoCoil) | NCT04359290
COVID-19 Patient Positioning Pragmatic Trial | NCT04359797
Tocilizumab Treatment in Patients With COVID-19 | NCT04363853
The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients (SIDIACO) | NCT04365517
The Prone Position in Covid-19 Affected Patients (PRON-COVID) | NCT04365959
Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); | NCT04375709
Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 (CLUSCO) | NCT04379544
Rehabilitation for People With COVID-19 in ICU (COVID_REHAB) | NCT04381338
Sitagliptin Treatment in Diabetic COVID-19 Positive Patients (SIDIACO-RETRO') | NCT04382794
Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury (TAC-COVID19) | NCT04395482
Evaluating Clinical Parameters of COVID-19 in Pregnancy (COpregVID) | NCT04470583
A Survey to Assess Effects of Covid-19 on Cardiovascular Patients | NCT04508920
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism | NCT04558125
Treatment With Pirfenidone for COVID-19 Related Severe ARDS | NCT04653831
Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis | NCT04920851
Study of Varespladib in Patients Hospitalized With Severe COVID-19 (STAIRS) | NCT04969991
Immune Modulation by Exosomes in COVID-19 (IMECOV19) | NCT05191381
Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia (FluCOP) | NCT05216614
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med (2020) 7.12
End-Stage Heart Failure With COVID-19: Strong Evidence of Myocardial Injury by 2019-nCoV. JACC Heart Fail (2020) 2.57
Respiratory support for patients with COVID-19 infection. Lancet Respir Med (2020) 0.75
COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med (2020) 0.75
Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China. Anaesth Crit Care Pain Med (2020) 0.75